PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Melodiol Global Health Limited (ME1.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU0000282840

Sector

Healthcare

Highlights

Market Cap

A$1.13M

EPS (TTM)

-A$7.64

Year Range

A$0.00 - A$0.45

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Melodiol Global Health Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Aug 18Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13Oct 20Oct 27
-100.00%
7.51%
ME1.AX (Melodiol Global Health Limited)
Benchmark (^GSPC)

Returns By Period


ME1.AX

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

2.90%

1M

3.70%

6M

10.94%

1Y

22.18%

5Y*

12.41%

10Y*

11.21%

*Annualized

Monthly Returns

The table below presents the monthly returns of ME1.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-57.50%-58.82%-28.57%-20.00%-50.00%-95.00%-33.33%-50.00%0.00%-99.92%
20235.00%-38.10%-19.23%4.76%-9.09%-30.00%57.14%-36.36%-21.43%-45.45%-33.33%0.00%-90.00%
20220.00%-18.29%7.46%-15.28%-13.11%-33.96%40.00%-20.41%-20.51%-0.00%-38.71%5.26%-75.61%
20218.33%7.69%-4.76%2.50%-29.27%-3.45%-21.43%18.18%-15.38%9.09%-20.00%-14.58%-54.44%
202032.00%-47.88%-31.40%15.25%0.00%-54.41%-0.00%12.90%8.57%-31.58%73.08%300.00%44.00%
2019-16.33%-5.49%-7.10%23.61%-5.62%25.00%-30.48%9.59%-4.50%-46.34%0.00%-39.02%-74.49%
20186.52%-8.67%-15.64%10.60%-14.97%-11.97%0.80%-2.38%-8.94%-25.89%-0.00%18.07%-46.74%
2017-2.13%39.13%139.06%-13.73%-40.15%41.77%-9.82%-1.98%4.04%4.85%115.74%-21.03%291.49%
201611.54%-18.97%-0.00%-9.62%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ME1.AX is 22, meaning it’s performing worse than 78% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ME1.AX is 2222
Overall Rank
The Sharpe Ratio Rank of ME1.AX is 3131
Sharpe Ratio Rank
The Sortino Ratio Rank of ME1.AX is 3131
Sortino Ratio Rank
The Omega Ratio Rank of ME1.AX is 3131
Omega Ratio Rank
The Calmar Ratio Rank of ME1.AX is 00
Calmar Ratio Rank
The Martin Ratio Rank of ME1.AX is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Melodiol Global Health Limited (ME1.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
ME1.AX
^GSPC

There is not enough data available to calculate the Sharpe ratio for Melodiol Global Health Limited. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio0.001.002.003.00Aug 18Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13Oct 20Oct 27
-0.24
3.39
ME1.AX (Melodiol Global Health Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Melodiol Global Health Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Aug 18Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13Oct 20Oct 27
-100.00%
0
ME1.AX (Melodiol Global Health Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Melodiol Global Health Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Melodiol Global Health Limited was 100.00%, occurring on Aug 5, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 28, 20171591Aug 5, 2024
-52.12%Mar 27, 201745May 31, 2017121Nov 20, 2017166
-47.22%Oct 25, 201653Jan 11, 201732Mar 2, 201785
-32.43%Mar 14, 20172Mar 15, 20171Mar 16, 20173
-6.67%Mar 17, 20171Mar 17, 20171Mar 22, 20172

Volatility

Volatility Chart

The current Melodiol Global Health Limited volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%Aug 18Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13Oct 20Oct 270
2.95%
ME1.AX (Melodiol Global Health Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Melodiol Global Health Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Melodiol Global Health Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab